StatPearls Publishing, Treasure Island (FL) Dorgalaleh A, Shahzad MS, Younesi MR et al (2013) Evaluation of liver and kidney function in favism patients
The companies must follow strict regulations for FDA approval which includes warnings about increased health risks and side effects
3.4 Gastrointestinal Side Effects and Secondary Risk Nausea, vomiting and diarrhoea are most common during dose escalation
Health authorities have warned that some compounded GLP-1 products may contain incorrect doses, different chemical formulations, or additional ingredients whose safety and effectiveness have not been established
Others notice it most when theyve gone long stretches without food, or during periods of intense weight loss
Note: The FDA tracks side effects of drugs it has approved